Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Taguchi

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Immunology Letters|November 18, 2005
Theory of proteolytic antibody occurrenceSudhir Paul, Yasuhiro Nishiyama, Stephanie Planque, et al.
Amino Acids|February 15, 2016
6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccineYoshio Fujita, Kazuyuki Hirai, Keigo Nishida, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 19, 2017
Role of the constant region domain in the structural diversity of human antibody light chainsEmi Hifumi, Hiroaki Taguchi, Ryuichi Kato, et al.
Clinical Rheumatology|August 16, 2024
The potential of interleukin-17 inhibitors treatment for reactive arthritis after transurethral resection of a bladder tumor and intravesical administration of bacillus calmette-guerin therapySho Ishigaki, Nobuhiko Kajio, Noritada Yoshikawa, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|June 18, 2023
Direct conversion of a general antibody to its catalytic antibody and corresponding applications -Importance and role of Pro95 in CDR-3Emi Hifumi, Hiroaki Taguchi, Tamami Nonaka, et al.
RSC Chemical Biology|August 30, 2021
Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 moleculeEmi Hifumi, Hiroaki Taguchi, Tamami Nonaka, et al.
Molecular Immunology|January 16, 2007
Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunitYasuhiro Nishiyama, Sangeeta Karle, Stephanie Planque, et al.
Scientific Reports|May 28, 2024
Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodiesEmi Hifumi, Yuina Ito, Moe Tsujita, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 13, 2016
Crystal structure of 6-de-oxy-α-l-psico-furan-oseAkihide Yoshihara, Tomohiko Ishii, Tatsuya Kamakura, et al.
Chemistry, an Asian Journal|October 2, 2019
Effects of Physical Damage in the Intermediate Phase on the Progression of Amyloid β FibrillizationRyu Tashiro, Hiroaki Taguchi, Kumi Hidaka, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Immunology Letters|November 18, 2005
Theory of proteolytic antibody occurrenceSudhir Paul, Yasuhiro Nishiyama, Stephanie Planque, et al.
Amino Acids|February 15, 2016
6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccineYoshio Fujita, Kazuyuki Hirai, Keigo Nishida, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 19, 2017
Role of the constant region domain in the structural diversity of human antibody light chainsEmi Hifumi, Hiroaki Taguchi, Ryuichi Kato, et al.
Clinical Rheumatology|August 16, 2024
The potential of interleukin-17 inhibitors treatment for reactive arthritis after transurethral resection of a bladder tumor and intravesical administration of bacillus calmette-guerin therapySho Ishigaki, Nobuhiko Kajio, Noritada Yoshikawa, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|June 18, 2023
Direct conversion of a general antibody to its catalytic antibody and corresponding applications -Importance and role of Pro95 in CDR-3Emi Hifumi, Hiroaki Taguchi, Tamami Nonaka, et al.
RSC Chemical Biology|August 30, 2021
Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 moleculeEmi Hifumi, Hiroaki Taguchi, Tamami Nonaka, et al.
Molecular Immunology|January 16, 2007
Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunitYasuhiro Nishiyama, Sangeeta Karle, Stephanie Planque, et al.
Scientific Reports|May 28, 2024
Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodiesEmi Hifumi, Yuina Ito, Moe Tsujita, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 13, 2016
Crystal structure of 6-de-oxy-α-l-psico-furan-oseAkihide Yoshihara, Tomohiko Ishii, Tatsuya Kamakura, et al.
Chemistry, an Asian Journal|October 2, 2019
Effects of Physical Damage in the Intermediate Phase on the Progression of Amyloid β FibrillizationRyu Tashiro, Hiroaki Taguchi, Kumi Hidaka, et al.
Pageof 7